U.S. authorities quiz AstraZeneca over heart drug trial

[riky]

U.S. authorities quiz AstraZeneca over heart drug trial

<p><a href="http://news.yahoo.com/u-authorities-quiz-astrazeneca-over-brilinta-clinical-trial-095327330--finance.html"><img src="http://l1.yimg.com/bt/api/res/1.2/8FgZAei8qohKnBq6f0A9aA--/YXBwaWQ9eW5ld3M7Zmk9ZmlsbDtoPTg2O3E9NzU7dz0xMzA-/http://media.zenfs.com/en_us/News/Reuters/2013-10-31T162610Z_1_CBRE99U19NQ00_RTROPTP_2_ASTRAZENECA-STRATEGY.JPG" width="130" height="86" alt="CEO of AstraZeneca, Pascal Soriot, poses for a photograph in this undated picture provided by AstraZeneca in London" align="left" title="CEO of AstraZeneca, Pascal Soriot, poses for a photograph in this undated picture provided by AstraZeneca in London" border="0" /></a>By Ben Hirschler LONDON (Reuters) - AstraZeneca is being investigated by U.S. authorities over a major clinical trial that was used to win marketing approval for its new heart drug Brilinta, casting fresh doubts over the medicine. Brilinta sales have been a disappointment since its launch two years ago, although AstraZeneca has recently stepped up marketing efforts and hopes that further clinical tests will underscore its value in preventing heart attacks. The British drugmaker said on Thursday it received a civil investigative demand from the U.S. Department of Justice (DOJ) 10 days ago, seeking documents and information regarding the so-called PLATO study. AstraZeneca plans to cooperate with the DOJ and Chief Executive Pascal Soriot said he was &quot;very confident&quot; in the findings of the clinical trial.</p><br clear="all"/>

Source: You are not allowed to view links. Register or Login